1. |
Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery:predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA, 1996, 276:300-306.
|
2. |
Usta E, Mustafi M, Walker T, et al. Resveratrol suppresses apoptosis in intact human cardiac tissue - in vitro model simulating extracorporeal circulation. J Cardiovasc Surg (Torino), 2011, 52 (3):399-409.
|
3. |
Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources.Circulation, 1996, 94:390-397.
|
4. |
Wang Z, Liang D, Fu Q, et al. Perioperative brain natriuretic peptide in off-pump coronary artery bypass. Acta Cardiol, 2010, 65 (3):297-301.
|
5. |
Hutfless R, Kazanegra R, Madani M, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol, 2004, 43 (10):1873-1879.
|
6. |
Sachdeva A, Horwich TB, Fonarow GC. Comparison of usefulness of each of five predictors of mortality and urgent transplantation in patients with advanced heart failure. Am J Cardiol, 2010, 106 (6):830-835.
|
7. |
Fellahi JL, Daccache G, Rubes D, et al. Does preoperative B-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard European System for Cardiac Operative Risk Evaluation after cardiac surgery ? J Cardiothorac Vasc Anesth, 2011, 25 (2):256-262.
|
8. |
Whiting P, Rutjes AW, Reitsma JB, et al. The development of QUADAS:a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol, 2003, 3:25.
|
9. |
Krzych LJ, Szurlej D, Kooldziej T, et al. Diagnostic accuracy of pre-operative NT-proBNP level in predicting short-term outcomes in coronary surgery:A pilot study. Kardiol Pol, 2011, 69:1121-1127.
|
10. |
Ata Y, Turk T, Ay D, et al. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Heart Surg Forum, 2009, 12 (4):E211-E216.
|
11. |
Gibson PH, Croal BL, Cuthbertson BH, et al. Use of preoperative natriuretic peptides and echocardiographic parameters in predicting new-onset atrial fibrillation after coronary artery bypass grafting:a prospective comparative study. Am Heart J, 2009, 158 (2):244-251.
|
12. |
Akazawa T, Nishihara H, Iwata H, et al. Preoperative plasma brain natriuretic peptide level is an independent predictor of postoperative atrial fibrillation following off-pump coronary artery bypass surgery. J Anesth, 2008, 22 (4):347-353.
|
13. |
Sarzi Braga S, Vaninetti R, Pedretti RF. Plasma B-type natriuretic peptide predicts atrial fibrillation during rehabilitation after cardiac surgery. Eur J Cardiovasc Prev Rehabil, 2008, 15 (4):460-466.
|
14. |
Ketch TR, Turner SJ, Sacrinty MT, et al. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting. Am Heart J, 2008, 156 (2):234-240.
|
15. |
Foroughi M, Rahimian H, Dabbagh A, et al. Postoperative N-terminal pro-brain natriuretic peptide level in coronary artery bypass surgery with ventricular dysfunction after perioperative glucose-insulin-potassium treatment. J Cardiothorac Vasc Anesth, 2012, 26 (4):631-636.
|
16. |
Ambwani J, Ubhrani D, Saad R, et al. Best evidence topic-cardiac general could atrial natriuretic peptide be a useful drug therapy for high-risk patients after cardiac surgery?Interact Cardiovasc Thorac Surg, 2009, 8 (4):474-478.
|
17. |
Sezai A, Hata M, Wakui S, et al. Efficacy of low-dose continuous infusion of alpha-human atrial natriuretic peptide (hANP) during cardiac surgery:possibility of postoperative left ventricular remodeling effect. Circ J, 2006, 70 (11):1426-1431.
|
18. |
Karthikeyan G, Moncur RA, Levine O, et al. Is a pre-operative brain natriuretic peptide or N-Terminal Pro-B-Type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery ? A systematic review and meta-analysis of observational studies.J Am Coll Cardiol, 2009, 54 (17):1599-1606.
|
19. |
Blankenberg S, Tonkin A, Kirby A, et al. Incorporating novelbiomarkers significantly improves risk stratification for coronary heart disease patients:The long-term intervention with pravastatin in ischaemic disease (LIPID)trial. Circulation, 2011, 124:A15520.
|
20. |
Tavakol M, Hassan KZ, Abdula RK, et al. Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations. Ann Thorac Surg, 2009, 88 (3):802-807.
|
21. |
毛斌, 陈菲, 邵娟娟, 等.非体外循环冠状动脉旁路移植术围术期脑钠肽变化特点及其临床意义.中国胸心血管外科临床杂志, 2011, 18 (4):309-312..
|
22. |
Nashef SA, Roques F, Hammill BG, et al. Validation of European system for cardiac operative risk evaluation (EuroSCORE) in North American cardiac surgery. Eur J Cardiothorac Surg, 2002, 22 (1):101-105.
|
23. |
Litton E, Ho KM. The use of pre-operative brain natriuretic peptides as a predictor of adverse outcomes after cardiac surgery:a systematic review and meta-analysis. Eur J Cardiothorac Surg, 2012, 41 (3):525-534.
|
24. |
Yap CH, Mohajeri M, Ihle BU, et al. Validation of euroscore model in an Australian patient population. ANZ J Surg, 2005, 75 (7):508-512.
|
25. |
Toumpoulis IK, Anagnostopoulos CE, Swistel DG, et al. Does EuroSCORE predict length of stay and specific postoperative complications after cardiac surgery ? Eur J Cardiothorac Surg, 2005, 27 (1):128-133.
|
26. |
Patel UD, Garg AX, Krumholz HM, et al. Preoperative serum brain natriuretic peptide and risk of acute kidney injury after cardiac surgery.Circulation, 2012, 125 (11):1347-1355.
|
27. |
Evrard P, Gonzalez M, Jamart J, et al. Prophylaxis of supraventricular and ventricular arrhythmias after coronary artery bypass grafting with low-dose sotalol. Ann Thorac Surg, 2000, 70 (1):151-156.
|
28. |
Karuppasamy P, Chaubey S, Dew T, et al. Remote intermittent ischemia before coronary artery bypass graft surgery:A strategy to reduce injury and inflammation?Basic Res Cardiol, 2011, 106 (4):511-519.
|
29. |
Steiner J, Guglin M. BNP or NTproBNP?A clinician's perspective. Int J Cardiol, 2008, 129:5-14.
|
30. |
Masson S, Latini R, Anand IS, et al. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure:the Valsartan Heart Failure (Val-HeFT) data. Clin Chem, 2006, 52 (8):1528-1538.
|